Indian generic drug manufacturer Wockhardt has been asked by America's Federal Drug Administration to conduct a global assessment of its plants to ensure that the drug produced by the company......
Ranbaxy has denied sabotage at its Toansa (Punjab) factory, which makes active pharmaceutical ingredients, by workers offered voluntary retirement had led to a ban by the US Food and Drug......
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office. These......
Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues faced by the domestic pharmaceutical industry because......
The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain. Ranbaxy whistle-blower Dinesh Thakur,......